Breaking News Instant updates and real-time market news.

PEP

PepsiCo

$134.12

(0.00%)

, IP

International Paper

$39.44

(0.00%)

09:40
10/03/19
10/03
09:40
10/03/19
09:40

Unusually active option classes on open October 3rd

Unusual total active option classes on open include: PepsiCo (PEP), International Paper (IP), Bed Bath & Beyond (BBBY), Gap (GPS), Cleveland-Cliffs (CLF), CrowdStrike Holdings (CRWD), Industrial Sector SPDR ETF (XLI), Tesla (TSLA), iShares High Yield Corporate Bond ETF (HYG), and Activision Blizzard (ATVI).

PEP

PepsiCo

$134.12

(0.00%)

IP

International Paper

$39.44

(0.00%)

BBBY

Bed Bath & Beyond

$10.04

(0.00%)

GPS

Gap

$16.45

(0.00%)

CLF

Cleveland-Cliffs

$6.73

0.1 (1.51%)

CRWD

Crowdstrike

$56.65

(0.00%)

XLI

Industrial Select Sector SPDR

$74.33

-1.47 (-1.94%)

TSLA

Tesla

$243.24

(0.00%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.12

(0.00%)

ATVI

Activision Blizzard

$52.26

(0.00%)

  • 03

    Oct

  • 03

    Oct

  • 18

    Oct

  • 23

    Oct

  • 31

    Oct

  • 21

    Nov

  • 12

    Dec

PEP PepsiCo
$134.12

(0.00%)

07/29/19
07/29/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Domino's Pizza (DPZ) initiated with a Sell at Deutsche Bank and a Neutral at Goldman Sachs. 2. Oaktree Specialty Lending (OCSL) initiated with a Neutral at Janney Montgomery Scott. 3. Chipotle (CMG) initiated with a Conviction Buy at Goldman Sachs, while McDonald's (MCD), Starbucks (SBUX), and Shake Shack (SHAK) were initiated with a Buy, Restaurant Brands (QSR) and Yum! Brands (YUM) were initiated with a Neutral, and Wendy's (WEN) and Jack in the Box (JACK) were initiated with a Sell. 4. PepsiCo (PEP) and Coca-Cola (KO) initiated with an Overweight at Atlantic Equities. 5. Dell Technologies (DELL) initiated with an Outperform at Wells Fargo. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/06/19
FBCO
09/06/19
NO CHANGE
Target $117
FBCO
Underperform
PepsiCo price target raised to $117 from $110 at Credit Suisse
Credit Suisse analyst Kaumil Gajrawala maintained an Underperform rating on PepsiCo and raised his price target to $117 from $110. In a research note to investors, the analyst says that a turnaround is likely to be driven by an improvement in its North American business, but believes "we are not yet at a sustainable inflection point that would allow PepsiCo to throttle back the spending" and deliver 8% EPS growth for 2020.
09/11/19
MSCO
09/11/19
NO CHANGE
Target $149
MSCO
Overweight
PepsiCo price target raised to $149 from $143 at Morgan Stanley
Morgan Stanley analyst Dara Mohsenian sees strong near-term revenue growth at PepsiCo being supported by an acceleration in U.S. scanner data and also believes the company has above peer topline growth potential over the longer term driven by its snacks business and international momentum. He also does not think Pepsi's high EPS visibility is fully priced into the stock given its discounted valuation compared to peers. Mohsenian reiterates an Overweight rating on PepsiCo and raised his price target on the shares to $149 from $143.
10/02/19
BMOC
10/02/19
NO CHANGE
Target $34
BMOC
Outperform
BMO Capital more optimistic about Keurig Dr Pepper generating merger synergies
BMO Capital analyst Amit Sharma is keeping his Outperform rating and $34 price target on Keurig Dr Pepper (KDP), citing its expected "sector leading" mid-teen earnings growth through 2021 along with his "greater confidence" in post-synergies earnings growth potential in high single digits. The analyst notes that investors are focusing on the company's coffee business while overlooking the "ingrained structural advantages" of its much-larger RTD beverage business, with consensus estimates modeling a "smaller" improvement than the expected North America sales trends at Coca-Cola (KO) and PepsiCo (PEP).
IP International Paper
$39.44

(0.00%)

06/24/19
06/24/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Sonoco (SON) downgraded to Sell from Neutral at Goldman Sachs with analyst Brian Maguire citing valuation. 2. Occidental Petroleum (OXY) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Devin McDermott saying he believes covering the 2020 dividend at current oil prices will require meaningful capital expenditure cuts, even though the Anadarko (APC) deal looks accretive to cash flow. 3. International Paper (IP) downgraded to Equal Weight from Overweight at Stephens with analyst Mark Connelly saying RISI decided to cut the price of containerboard $10 "just three days after investors breathed a sigh of relief on encouraging supply-demand fundamentals." 4. Shopify (SHOP) downgraded to Neutral from Buy at Roth Capital with analyst Darren Aftahi saying he remains positive on its underlying business prospects following the company's Unite conference and investor day but not on the stock's valuation, which has increased in the wake of the event. 5. Spotify (SPOT) downgraded to Underperform from In Line at Evercore ISI with analyst Kevin Rippey saying the recent rally in the stock "reflects an overly optimistic view" on the company's gross margin path and potential label negotiation outcomes. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/19
SBSH
07/11/19
DOWNGRADE
SBSH
Neutral
International Paper downgraded to Neutral from Buy at Citi
Citi analyst Anthony Pettinari downgraded International Paper to Neutral from Buy.
07/15/19
KEYB
07/15/19
DOWNGRADE
Target $38
KEYB
Underweight
International Paper downgraded to Underweight from Sector Weight at KeyBanc
KeyBanc analyst Adam Josephson downgraded International Paper to Underweight from Sector Weight with a $38 price target.
07/15/19
07/15/19
DOWNGRADE
Target $38

Underweight
International Paper downgraded to Underweight at KeyBanc
As previously reported, KeyBanc analyst Adam Josephson downgraded International Paper to Underweight from Sector Weight with a $38 price target. The analyst believes his below-consensus estimates are biased downward rather than upward given worsening fundamentals in containerboard, pulp, and uncoated freesheet.
BBBY Bed Bath & Beyond
$10.04

(0.00%)

09/30/19
WEDB
09/30/19
UPGRADE
Target $16
WEDB
Outperform
Wedbush upgrades Bed Bath & Beyond to Outperform, sees 62% upside potential
Wedbush analyst Seth Basham upgraded Bed Bath & Beyond to Outperform from Neutral and raised his price target for the shares to $16 from $14, which represents 62% upside potential. The retailer closed Friday up 9c to $9.89. Turning around declining retailers is a very difficult task, particularly amidst unfavorable secular trends and soft industry sales growth, but Bed Bath & Beyond has a "good chance of stabilization" in earnings over the next two years as its changes take hold, Basham tells investors in a research note. The company has a reconstituted board with "much-improved" governance, is resetting its cost structure, has a plan to reduce inventory by 35%, is rapidly refreshing stores to improve the shopping experience, has launched two private label brands, and is evaluating opportunities to leverage its store lease expiration cadence and sell noncore assets, explains the analyst. Further, Basham believes buy-side expectations are "very low."
10/03/19
JEFF
10/03/19
NO CHANGE
Target $11
JEFF
Hold
Bed Bath & Beyond price target lowered to $11 from $13 at Jefferies
Jefferies analyst Jonathan Matuszewski lowered his price target for Bed Bath & Beyond to $11 from $13 and reiterates a Hold rating on the shares following last night's fiscal Q2 results. An inflection in gross margin contributed to a slight earnings beat excluding tax benefits, though comps worsened with Q2, setting a new multi-decade low, Matuszewski tells investors in a research note. He believes the "muted" stock reaction post earnings A muted reaction in suggests investors are giving a "pass" on soft top-line fundamentals and underscores optimism in the forthcoming CEO. The analyst, however, sees heightened execution risk with Bed Bath & Beyond needing to reach over 75% of its annual earnings in Q4.
10/03/19
LOOP
10/03/19
NO CHANGE
Target $10
LOOP
Hold
Bed Bath & Beyond price target lowered to $10 from $12 at Loop Capital
Loop Capital analyst Anthony Chukumba lowered his price target on Bed Bath & Beyond to $10 and kept his Hold rating after its Q2 results, saying the company's update do not give him "much reason" to believe that it is progressing with a "significant turnaround". The analyst is particularly concerned with the large same-store-sales decline at Bed Bath & Beyond, particularly in light of the "strong" top-line results by other covered home furnishings retailers and the improving housing market in the U.S. Chukumba further cites the company's operating margin contraction of 50bps, driven by the SG&A expense deleverage.
09/30/19
09/30/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. TSMC (TSM) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Bruce Lu saying after a re-examination of industry capacity builds and order revisions, he thinks he's underestimating the positive impacts on TSMC arising from trade uncertainty. 2. Wells Fargo (WFC) upgraded to Buy from Hold at Argus with analyst Stephen Biggar citing the company's appointment of Charlie Scharf as its new CEO. 3. Cigna (CI) upgraded to Outperform from Market Perform at BMO Capital with analyst Matthew Borsch claiming that the current 8-times his expected forward earnings valuation multiple is "attractive" as the stock represents a "better hedge" against political and health policy uncertainty. 4. Bed Bath & Beyond (BBBY) upgraded to Outperform from Neutral at Wedbush with analyst Seth Basham saying turning around declining retailers is a very difficult task, particularly amidst unfavorable secular trends and soft industry sales growth, but Bed Bath & Beyond has a "good chance of stabilization" in earnings over the next two years as its changes take hold. 5. Restaurant Brands (QSR) upgraded to Neutral from Underperform at Longbow with analyst Alton Stump saying after calls with U.S. Burger King franchisees, he believes same-store sales for Restaurant Brands' Burger King concept were up 4.5%-5.0% in Q3 ahead of his prior estimate of 2.0% growth and consensus at up 3.4%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GPS Gap
$16.45

(0.00%)

09/25/19
RBCM
09/25/19
NO CHANGE
Target $19
RBCM
Sector Perform
Gap price target lowered to $19 from $20 at RBC Capital
RBC Capital analyst Kate Fitzsimmons nudged her price target on Gap lower to $19 and kept her Sector Perform rating after meeting with the company's Investor Relations executives following its Analyst Day. The analyst notes that the management continues to focus on executing its Old Navy spin, but warns that investors are unlikely to give the stock much credit because of the negative Old Navy comps and the "skepticism" about the trajectories of the two businesses. Fitzsimmons adds that her neutral stance is driven by the lack of visibility on the sales and margin inflection at the Gap Brand, with the turnaround expected to "take some time".
09/23/19
SPIN
09/23/19
INITIATION
Target $23
SPIN
Buy
Gap initiated with a Buy at Spin-Off Research
Spin-Off Research started Gap with a Buy rating and $23 price target.
09/17/19
ARGS
09/17/19
NO CHANGE
ARGS
Hold
Gap still facing product assortment, discounting issues, says Argus
Argus analyst Deborah Ciervo kept her Hold rating on Gap shares, saying that while the management's "aggressive" efforts to restructure its business and adapt to the changes in the retail environment are encouraging, the company is still facing challenges with "product assortment issues and increased levels of discounting". The analyst further cites Gap's decline in comp growth and weaker traffic trends as seen in the most recent reported quarter that warrant a neutral stance.
10/01/19
BOFA
10/01/19
NO CHANGE
BOFA
Top 10 US Ideas for Q4 at BofA/Merrill
BofA/Merrill introduced the Top 10 US Ideas for Q4 2019. The list's seven Buys are Aramark (ARMK), Salesforce (CRM), Disney (DIS), Dover (DOV), New York Community Bancorp (NYCB), Raytheon (RTN), and Target (TGT). Underperform's are Floor & Decor (FND), Gap (GPS), and Terex (TEX).
CLF Cleveland-Cliffs
$6.73

0.1 (1.51%)

10/01/19
RILY
10/01/19
NO CHANGE
Target $13
RILY
Buy
Cleveland-Cliffs price target lowered to $13 from $16 at B. Riley FBR
B. Riley FBR analyst Lucas Pipes lowered his price target for Cleveland-Cliffs to $13 from $16 to reflect the "evolving" macro environment and price environment. Last month, Platts reported a 35% decline in Atlantic pellet premiums to $40/dmt, the analyst points out. The analyst estimates this reduction lowered Cleveland-Cliffs' sales margins by approximately $10/lt on an annual basis. Until we see a material improvement in steel mill economics, Atlantic pellet premiums pricing could stay at these current levels for the next several quarters, Pipes tells investors in a research note. Nonetheless, the analyst continues to believe that Cleveland-Cliff is an attractive stock with "substantial upside even in the current price environment." He keeps a Buy rating on the shares.
09/23/19
JPMS
09/23/19
DOWNGRADE
Target $8
JPMS
Neutral
Cleveland-Cliffs downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Michael Gambardella downgraded Cleveland-Cliffs to Neutral from Overweight and lowered his price target for the shares to $8 from $14.
09/23/19
JPMS
09/23/19
DOWNGRADE
Target $8
JPMS
Neutral
JPMorgan downgrades Cleveland-Cliffs to Neutral on lower pellet premiums
JPMorgan analyst Michael Gambardella downgraded Cleveland-Cliffs to Neutral from Overweight and lowered his price target for the shares to $8 from $14. Given the recent downward shift in pellet premiums as well as the weakness in steel prices, the analyst now expects pricing levels to be lower than he had previously anticipated. As a result, Gambardella expects some earnings pullback for Cleveland-Cliffs in 2020. However, he continues to think the company has a "defensible" core pellet business with "intriguing" growth potential from HBI.
09/23/19
09/23/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alcoa (AA) downgraded to Neutral from Buy at Goldman Sachs. 2. Commercial Metals (CMC) was downgraded to Neutral from Buy at Goldman Sachs while Schnitzer Steel (SCHN) was downgraded to Sell from Neutral. 3. AK Steel (AKS) was downgraded to Underweight from Overweight at JPMorgan while Cleveland-Cliffs (CLF) and U.S. Steel (X) were downgraded to Neutral from Overweight. 4. Clorox (CLX) downgraded to Underweight from Equal Weight at Barclays. 5. Spirit Airlines (SAVE) downgraded to Equal Weight from Overweight at Stephens with analyst Jack Atkins saying with its heavy Southeast and Caribbean exposure, Spirit significantly lowered its Q3 guidance in early September due to Hurricane Dorian. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CRWD Crowdstrike
$56.65

(0.00%)

10/02/19
RHCO
10/02/19
UPGRADE
Target $80
RHCO
Buy
Crowdstrike upgraded to Buy from Hold at SunTrust
SunTrust analyst Joel Fishbein upgraded Crowdstrike to Buy from Hold with an unchanged price target of $80.
10/02/19
RHCO
10/02/19
UPGRADE
Target $80
RHCO
Buy
SunTrust upgrades 'category-defining' Crowdstrike to Buy from Hold
SunTrust analyst Joel Fishbein upgraded Crowdstrike to Buy from Hold with an $80 price target after taking over coverage from Terry Tillman. The company has developed a "category-defining" cloud platform for cyber security, a market that is "ripe for disruption," Fishbein tells investors in a research note. While the shares are not inexpensive, there are "several catalysts," including success in trial to pay, deeper penetration in both federal and international markets, and leverage from Crowdstrike's Dell relationship, contends the analyst.
09/25/19
BARD
09/25/19
INITIATION
Target $75
BARD
Neutral
Crowdstrike initiated with a Neutral at Baird
Baird analyst Jonathan Ruykhaver initiated CrowdStrike with a Neutral and $75 price target citing valuation and questions whether the company can meaningfully exceed high expectations.
09/06/19
MACQ
09/06/19
NO CHANGE
Target $105
MACQ
Outperform
Crowdstrike price target raised to $105 from $100 at Macquarie
Macquarie analyst Sarah Hindlian said CrowdStrike reported "another very strong quarter," noting that its 730 net customer adds were more than double her 315 forecast. Crowdstrike management also "tackled concerns around recent M&A and its channel impacts...head on," suggesting both limited current exposure as well as no built in guidance from the Dell channel, according to Hindlian. She keeps an Outperform rating and raised her price target on Crowdstrike shares to $105 from $100 following the quarterly report.
XLI Industrial Select Sector SPDR
$74.33

-1.47 (-1.94%)

05/30/19
DBAB
05/30/19
NO CHANGE
DBAB
Hold
Deutsche Bank makes 'Catalyst Call Buy' on UPS
Deutsche Bank analyst Amit Mehrotra added shares of UPS (UPS) as a "Catalyst Call Buy," hedged against the Industrial Select Sector SPDR (XLI). The analyst views UPS as defensive at current levels in an environment of heightened China/U.S. trade concerns. This is supported by the company's "healthy" balance sheet, "high" dividend and "manageable" China/trade exposure, Mehrotra tells investors in a research note. He estimates estimate UPS's China sales are just $1.5B on a revenue base of $75. Nonetheless, the analyst's long-term fundamental rating on UPS remains Hold.
07/24/19
GABE
07/24/19
DOWNGRADE
GABE
Hold
Gabelli downgrades Stanley Black & Decker to Hold on valuation
As previously reported, Gabelli analyst Justin Bergner downgraded Stanley Black & Decker (SWK) to Hold from Buy, citing valuation following the stock's recent outperformance compared to the Industrial Select Sector SPDR (XLI). Normalized free cash flow conversion "suggests [Stanley] is not as cheap as P/E would suggest," added Bergner.
TSLA Tesla
$243.24

(0.00%)

10/03/19
SBSH
10/03/19
NO CHANGE
Target $1941
SBSH
Sell
Citi expects pullback in Tesla shares from last night's delivery report
Citi analyst Itay Michaeli expects Tesla's Q3 delivery report last night to drive a selloff in the stock. The 97,000 deliveries fell short of recently inflated expectations stemming from a media reported internal e-mail suggesting the company had a shot at delivering 100,000 vehicles, Michaeli tells investors in a research note. Further, the release didn't specifically confirm Tesla's 2019 delivery guidance of 360,000-400,000, adds the analyst. Michaeli points out that meeting the low-end of the range now requires Tesla to deliver 105,000 units in Q4. He keeps a Sell rating on the shares with a $191 price target. Tesla in premarket trading is down $11.75, or 5%, to $231.38.
10/03/19
BERN
10/03/19
NO CHANGE
BERN
Bernstein sees Tesla collective demand data points as positive
Following Tesla's quarterly vehicle production/deliveries announcement, Bernstein analyst A.M. Sacconaghi, Jr. notes that relative to expectations two weeks ago, this would've been a beat, but instead the results were likely "modestly disappointing" given a leaked email last week from Elon Musk targeting 100K deliveries. On net, the analyst sees collective demand data points as positive, with orders growing sequentially for the second quarter in a row, Model 3 inventory levels remaining low at less than 3 weeks, U.S. deliveries appearing to have been flattish sequentially, and orders appearing to have been strong in Europe.
10/03/19
OPCO
10/03/19
NO CHANGE
Target $356
OPCO
Outperform
Tesla delivery number 'a positive result,' says Oppenheimer
Oppenheimer analyst Colin Rusch notes that while Tesla's 97k vehicles delivered in Q3 did not meet the 100K level that a recent tweet from its CEO suggested the company might reach for the quarter, he believes it is "a positive result" for Tesla. All eyes will now turn to manufacturing margins and cash flow for the quarter, he contends. Rusch believes the mix of shipments to Europe will be a key driver for margins as the company is enjoying higher value mix in Europe and is shipping increasing volumes to Europe. The analyst expects shares to recover from the aftermarket selloff as investors process the potential cash generation for the quarter, which could be similar or better than the $864M of operating cash generated in Q2. He reiterates an Outperform rating and a $356 price target on the shares.
10/03/19
RBCM
10/03/19
NO CHANGE
RBCM
Underperform
Tesla focus shifts on earnings, says RBC Capital
RBC Capital analyst Joseph Spak is keeping his Underperform rating on Tesla after its Q3 delivery figures, noting that while the 97K was above consensus 95K, it was below the "whisper" forecast of 100K speculated by media outlets. The analyst believes that investor focus will now fall on earnings, with a rise in Model S/X car sales becoming subject to lease accounting - 15% vs. 10% last quarter. Spak adds that Tesla's "inventory" - or cumulative excess production - still stands around 20K, even though Q3 marked the 2nd consecutive quarter when deliveries exceeded production.
HYG iShares iBoxx $ High Yield Corporate Bond
$86.12

(0.00%)

ATVI Activision Blizzard
$52.26

(0.00%)

09/24/19
KEYB
09/24/19
NO CHANGE
Target $60
KEYB
Overweight
'Call of Duty' record-breaking beta bodes well for launch, says KeyBanc
KeyBanc analyst Tyler Parker noted that Activision Blizzard said that the open beta this past weekend for "Call of Duty: Modern Warfare" was the largest in the franchise's history and broke multiple records, which he said points to the ongoing interest in the franchise and bodes well for the odds of a successful launch on October 25. The analyst, who is modeling 21M units in Q4 for the game and sees it being set up well to at least meet that expectation, keeps an Overweight rating and $60 price target on Activision Blizzard shares.
10/02/19
10/02/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Charles Schwab (SCHW), TD Ameritrade (AMTD), and E-Trade (ETFC) double-downgraded to Underweight from Overweight at Barclays. 2. Monster Beverage (MNST) downgraded to Neutral from Buy at Guggenheim with analyst Laurent Grandet citing his view that the stock will be range-bound until the market can better gauge the impact of the upcoming U.S. launch of Coca-Cola (KO) Energy, which is planned for January. 3. Vermilion Energy (VET) downgraded to Sector Perform from Outperform at National Bank. 4. Activision Blizzard (ATVI) downgraded to Underperform from Market Perform at Bernstein with analyst Todd Juenger saying he cannot reconcile the current stock price with the company's risk-adjusted fundamentals. 5. Louisiana-Pacific (LPX) downgraded to Neutral from Buy at Longbow with analyst Garik Shmois saying oriented strand board pricing hasn't accelerated as quickly as we previously anticipated. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/02/19
10/02/19
DOWNGRADE
Target $43

Underperform
Activision Blizzard downgraded to Underperform at Bernstein
As previously reported, Bernstein analyst Todd Juenger downgraded Activision Blizzard to Underperform from Market Perform as he cannot reconcile the current stock price with the company's risk-adjusted fundamentals. Furthermore, the analyst believes the market is "paying too much for the hope" this is the trough and things can only get better. Juenger raised his price target on the stock to $43 from $41.
10/02/19
BERN
10/02/19
DOWNGRADE
BERN
Underperform
Activision Blizzard downgraded to Underperform from Market Perform at Bernstein

TODAY'S FREE FLY STORIES

PAYS

Paysign

$11.27

-0.56 (-4.73%)

20:32
11/14/19
11/14
20:32
11/14/19
20:32
Initiation
Paysign initiated  »

Paysign initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 25

    Nov

  • 26

    Nov

LPTX

Leap Therapeutics

$0.57

-0.5922 (-50.83%)

20:25
11/14/19
11/14
20:25
11/14/19
20:25
Downgrade
Leap Therapeutics rating change  »

Leap Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNT

Fortinet

$100.07

0.38 (0.38%)

20:25
11/14/19
11/14
20:25
11/14/19
20:25
Upgrade
Fortinet rating change  »

Fortinet upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 18

    Nov

  • 19

    Nov

  • 05

    Dec

  • 06

    Dec

  • 09

    Dec

  • 12

    Dec

JD

JD.com

$33.57

0.21 (0.63%)

, WVE

Wave Life Sciences

$27.90

-0.07 (-0.25%)

20:25
11/14/19
11/14
20:25
11/14/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JD

JD.com

$33.57

0.21 (0.63%)

WVE

Wave Life Sciences

$27.90

-0.07 (-0.25%)

RYTM

Rhythm Pharmaceuticals

$21.52

0.38 (1.80%)

JCP

J.C. Penney

$1.10

0.01 (0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 09

    Dec

SBS

Sabesp

$12.21

-0.02 (-0.16%)

20:22
11/14/19
11/14
20:22
11/14/19
20:22
Earnings
Sabesp reports Q3 adjusted EBITDA up 109.8% at BRL3.01B »

Reports Q3 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

LINX

Linx S.A.

$7.11

-0.8 (-10.11%)

19:16
11/14/19
11/14
19:16
11/14/19
19:16
Recommendations
Linx S.A. analyst commentary at Jefferies »

Linx S.A. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CNP

CenterPoint Energy

$26.68

-1.42 (-5.05%)

19:12
11/14/19
11/14
19:12
11/14/19
19:12
Downgrade
CenterPoint Energy rating change at Credit Suisse »

CenterPoint Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$309.54

0.46 (0.15%)

19:09
11/14/19
11/14
19:09
11/14/19
19:09
Periodicals
Kudlow says U.S. near trade agreement with China, Reuters says »

White House economic…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$309.54

0.46 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$75.55

-0.54 (-0.71%)

18:41
11/14/19
11/14
18:41
11/14/19
18:41
Hot Stocks
BioMarin CEO: Our products have a very long life cycle »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

OXY

Occidental Petroleum

$37.76

-0.36 (-0.94%)

18:38
11/14/19
11/14
18:38
11/14/19
18:38
Periodicals
Judge rejects Icahn's suit seeking Occidental acquisition records, Reuters says »

A Delaware court judge…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTCH

Farfetch

$7.49

-0.54 (-6.72%)

, DGII

Digi International

$15.10

0.33 (2.23%)

18:35
11/14/19
11/14
18:35
11/14/19
18:35
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

FTCH

Farfetch

$7.49

-0.54 (-6.72%)

DGII

Digi International

$15.10

0.33 (2.23%)

AMAT

Applied Materials

$56.89

-0.24 (-0.42%)

KLIC

Kulicke & Soffa

$25.18

-0.22 (-0.87%)

HP

Helmerich & Payne

$39.30

0.04 (0.10%)

WPM

Wheaton Precious Metals

$26.47

-0.12 (-0.45%)

RDNT

RadNet

$15.92

0.09 (0.57%)

RH

RH

$175.19

1.98 (1.14%)

ACB

Aurora Cannabis

$3.29

-0.25 (-7.06%)

OSMT

Osmotica Pharmaceuticals

$4.00

-0.03 (-0.74%)

GLOB

Globant

$108.99

3.975 (3.79%)

DLB

Dolby

$65.56

-0.14 (-0.21%)

NVDA

Nvidia

$209.88

1.33 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 20

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

  • 13

    Dec

  • 06

    Jan

VIA

Viacom

$25.31

0.175 (0.70%)

, VIAB

Viacom

$22.48

0.44 (2.00%)

18:24
11/14/19
11/14
18:24
11/14/19
18:24
Hot Stocks
Viacom CEO: The road ahead for the company is very exciting »

In an interview on…

VIA

Viacom

$25.31

0.175 (0.70%)

VIAB

Viacom

$22.48

0.44 (2.00%)

CBS

CBS

$37.62

0.78 (2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 09

    Dec

NVDA

Nvidia

$209.88

1.33 (0.64%)

18:22
11/14/19
11/14
18:22
11/14/19
18:22
Hot Stocks
Breaking Hot Stocks news story on Nvidia »

Nvidia CFO says continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

NVDA

Nvidia

$209.88

1.33 (0.64%)

18:04
11/14/19
11/14
18:04
11/14/19
18:04
Hot Stocks
Nvidia CEO says Q4 will be much stronger driven by AI and inference »

Says computational…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

BABA

Alibaba

$182.69

0.21 (0.12%)

17:50
11/14/19
11/14
17:50
11/14/19
17:50
Syndicate
Alibaba launches Hong Kong IPO »

Alibaba Group Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

17:49
11/14/19
11/14
17:49
11/14/19
17:49
Conference/Events
William Blair SaaS analyst to hold a luncheon meeting »

SaaS Analyst Pfau holds a…

HP

Helmerich & Payne

$39.30

0.04 (0.10%)

17:49
11/14/19
11/14
17:49
11/14/19
17:49
Earnings
Helmerich & Payne sees FY20 CapEx approximately $275M-$300M »

57-62% expected for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

PPG

PPG

$129.82

-0.5 (-0.38%)

, PG

Procter & Gamble

$120.49

-0.15 (-0.12%)

17:49
11/14/19
11/14
17:49
11/14/19
17:49
Hot Stocks
Trian Fund exits PPG, cuts Wendy's in Q3 »

Nelson Peltz' Trian…

PPG

PPG

$129.82

-0.5 (-0.38%)

PG

Procter & Gamble

$120.49

-0.15 (-0.12%)

MDLZ

Mondelez

$52.90

0.2 (0.38%)

LM

Legg Mason

$38.60

-0.22 (-0.57%)

GE

General Electric

$11.30

-0.01 (-0.09%)

WEN

Wendy's

$20.90

-0.01 (-0.05%)

BK

BNY Mellon

$48.42

0.07 (0.14%)

SYY

Sysco

$81.51

0.27 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 02

    Dec

  • 11

    Dec

  • 16

    Jan

  • 29

    Jan

HP

Helmerich & Payne

$39.30

0.04 (0.10%)

17:48
11/14/19
11/14
17:48
11/14/19
17:48
Earnings
Helmerich & Payne reports Q4 cont ops EPS 38c, consensus 23c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

17:47
11/14/19
11/14
17:47
11/14/19
17:47
Conference/Events
DA Davidson software analysts to hold a dinner meeting »

Analysts host a Security…

MDCO

The Medicines Co.

$50.89

-1.905 (-3.61%)

17:46
11/14/19
11/14
17:46
11/14/19
17:46
Conference/Events
Roth Capital pharmaceuticals analysts to hold a luncheon »

Analysts host Dr. John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

NVDA

Nvidia

$209.88

1.33 (0.64%)

17:44
11/14/19
11/14
17:44
11/14/19
17:44
Hot Stocks
Nvidia CFO says Q3 decline in automotive revenue driven by one-time item »

Says AI cockbit business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

CPE

Callon Petroleum

$4.20

-0.265 (-5.94%)

, PSDO

Presidio

$16.56

-0.02 (-0.12%)

17:44
11/14/19
11/14
17:44
11/14/19
17:44
Hot Stocks
Paulson adds Callon Petroleum, lowers stake in Lyft in Q3 »

John Paulson's…

CPE

Callon Petroleum

$4.20

-0.265 (-5.94%)

PSDO

Presidio

$16.56

-0.02 (-0.12%)

OSG

Overseas Shipholding

$1.84

0.045 (2.51%)

STC

Stewart

$43.10

0.11 (0.26%)

AGN

Allergan

$182.47

0.91 (0.50%)

HZNP

Horizon Pharma

$29.82

-0.48 (-1.58%)

ONCE

Spark Therapeutics

$110.78

-0.65 (-0.58%)

MYL

Mylan

$17.26

-0.01 (-0.06%)

S

Sprint

$5.86

-0.21 (-3.46%)

LYFT

Lyft

$41.90

-1.39 (-3.21%)

TMUS

T-Mobile

$76.87

-1.15 (-1.47%)

PCG

PG&E

$6.70

-0.19 (-2.76%)

WCG

WellCare

$301.86

-2.56 (-0.84%)

TSU

Tim Participacoes

$15.53

0.44 (2.92%)

GLD

SPDR Gold Shares

$138.57

0.59 (0.43%)

BHC

Bausch Health

$27.77

0.38 (1.39%)

CELG

Celgene

$110.03

-0.42 (-0.38%)

DISCK

Discovery Inc.

$28.04

0.12 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 18

    Nov

  • 19

    Nov

  • 19

    Nov

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 07

    Jan

  • 25

    Mar

  • 04

    Apr

17:41
11/14/19
11/14
17:41
11/14/19
17:41
Conference/Events
BTIG energy analysts to hold a luncheon »

Energy Analysts host…

17:40
11/14/19
11/14
17:40
11/14/19
17:40
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.